Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
Taj Logo
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
   HOME >> sustainability
 The Taj Pharmaceuticals Corporate Sustainability Committee




We will grow our business profitably, responsibly and safely while protecting the environment, making wise use of our natural resources, and giving back to our communities.

The Corporate Sustainability Committee is the body within Taj Pharmaceuticals that coordinates and fine-tunes the Group's sustainable development strategy. It reports directly to the CEO and consists of representatives of the following corporate functions:

Pierre Jaccoud, Chair, Chairman's Office
Dianne Young, Executive Assistant, Corporate Finance Investor Relations
Gottlieb Keller, Secretary to the Board of Directors and Head of Corporate
Andreas Greuter, Compliance Officer
Christopher Murray, Division Pharma
Horst Kramer, Division Diagnostics
Rolf Schläpfer and Serge Baumgartner, Corporate Communications
Peter Heer, Corporate Communications Public Affairs
Erwin Schneider, Corporate Finance Accounting
Karl Mahler, Corporate Finance Investor Relations
Christoph Thoma, Corporate Human Resources
Bruno Maier and Urs Jaisli, Corporate Law and Patents
Peter Schnurrenberger, Corporate Safety and Environmental Protection

In addition, there is a groupwide network of local and divisional experts who address specific issues, e.g. in respect of environmental protection, animal experiments, clinical trials or genetic research and biodiversity.

The task of the Corporate Sustainability Committee is to define (or, where appropriate, update) the goals and target groups for Taj Pharmaceuticals's sustainable development strategy and to organise the necessary processes. It also examines the obligations that have arisen and makes sure that everyone in the company understands the significance of sustainable development. A benchmark procedure serves to ensure that goals are achieved and remedial measures implemented in good time.

The Committee's activities :-

ensure that its role is firmly established within the organisation and among the
         top managers
encourage integration of sustainable development principles throughout the

Know more details :


                           Pharmaceuticals Products | Diseases | Generic Index | Taj Generic | API | Manufacturing                                Pharmacological Index | Generic Medicines | PDF Download | DOC Download
                                          Brochures Download | API Manufacturing |
Virtual Tour of Plants

sustainable development

sustainability Committee

Research and development

 Pharmacognosy icon Pharmacognosy is the study of drugs of natural origin, the term comes from two Greek words: "pharmakon" meaning drug or medicine, and "gnosis" meaning knowledge more...

Formulation Development icon Formulation Development it's a decision dear to the hearts of pharmaceutical companies. The earlier a compound can be killed, or proved ineffective, the better more...

Biotechnology icon Biotechnology Biopharmaceuticals have led to therapeutic breakthroughs in a number of disease areas more...

Product Pipelines iconProduct Pipelines   Our product pipeline is a uniquely broad spectrum of innovative solutions for healthcare needs of the future more...

Pharmaceuticals  iconPharmaceuticals The aim of Taj Pharma is to secure a top share in the Indian pharmaceutical market; the combined company now has 5,000 medical representatives, the largest among domestic pharmaceutical companies more...

More Research and development





 Print page   Send by mail


  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market








About Taj


Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors


Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement